Valchek Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Valsartan

Indications/Uses

HTN alone or in combination w/ other antihypertensive agents.

Click to view Valchek detailed prescribing information

Dosage/Direction for Use

80 or 160 mg once daily as monotherapy in adult patients who are not vol-depleted. May be increased to max of 320 mg or be added a diuretic if additional antihypertensive effect is required.

Click to view Valchek detailed prescribing information

Overdosage

View Valchek overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

Click to view Valchek detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Valchek detailed prescribing information

Special Precautions

Correct symptomatic hypotension prior to treatment. Heart failure. Unilateral or bilateral renal artery stenosis. Monitor renal function periodically. Mild to moderate hepatic impairment including biliary obstructive disorders. Pregnancy & lactation. Neonates. Not recommended for paed patients <6 yr. Elderly.

Click to view Valchek detailed prescribing information

Use In Pregnancy & Lactation

Click to view Valchek detailed prescribing information

Adverse Reactions

Allergic reaction, asthenia; palpitations; pruritus, rash; constipation, dry mouth, dyspepsia, flatulence; back pain, muscle cramps, myalgia; anxiety, insomnia, paresthesia, somnolence; dyspnea; vertigo; impotence.

Click to view Valchek detailed prescribing information

Drug Interactions

Systemic exposure may be increased w/ inhibitors of hepatic uptake transporter OATP1B1 (eg, rifampin, cyclosporine) or hepatic efflux transporter MRP2 (eg, ritonavir). May increase serum K & creatinine (in heart failure patients) w/ other agents that block the renin-angiotensin system, K sparing diuretics (eg, spironolactone, triamterene, amiloride), K supplements, or K-containing salt substitutes. Renal function may deteriorate w/ NSAIDS in elderly, vol-depleted patients or those w/ compromised renal function. Antihypertensive effect may be attenuated w/ NSAIDS (eg, selective COX-2 inhibitors).

Click to view Valchek detailed prescribing information

Storage

View Valchek storage conditions for details to ensure optimal shelf-life.

Description

View Valchek description for details of the chemical structure and excipients (inactive components).

Action

View Valchek mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Angiotensin II Antagonists

ATC Classification

C09CA03 - valsartan ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.

Regulatory Classification

POM

Presentation/Packing

Form

Valchek FC tab 160 mg

Packing/Price

10 × 10's

Form

Valchek FC tab 80 mg

Packing/Price

10 × 10's

Valchek

valsartan

Manufacturer:

Mepro Pharma

Distributor:

Maxxcare

Marketer:

Lupin